Canaan Partners
http://www.canaan.com/homeCanaan Partners is a venture capital firm that invests in early stage technology and healthcare companies. Since its founding in 1987, Canaan has invested in more than 250 companies including DoubleClick and Match.com.
View More Recent Stories
-
Victorious Launches Superfan App Platform for the World’s Biggest Digital Creators
-
Marvel Contest of Champions Unveils New Game Update in Celebration of Marvel’s Avengers: Age of Ultron Feature Film
-
Form 13F-HR Canaan Partners VII LLC For: Mar 31
-
CytomX to Present Overview of Precision Cancer Immunotherapies at the Jefferies Immuno-Oncology Summit
-
Destiny Calls! Spirit Lords is Now Available on the App Store and Google Play
-
Rocketrip Customers Save $238 Per Business Trip in Q1 2015
-
The RealReal Raises $40 Million to Accelerate Growth
-
Kabam to Launch Marvel Contest of Champions in China
-
CircleUp Portfolio Companies Average 90% Annual Revenue Growth
-
Vator Splash Tackles Tech Diversity; Offers Lessons from Venture Funders and "Unicorns"
-
Kabam and Universal Partnerships & Licensing Announce Fast & Furious: Legacy is Now Available
-
CytomX Appoints Immuno-Oncology Leader Rachel Humphrey, M.D., to Board of Directors
-
Truveris Launches Pharmacy Stop Loss Insurance Platform to Protect Employers from Rising Benefit Costs
-
Form 13F-HR Canaan Partners VII LLC For: Dec 31
-
Form 13F-HR Canaan Partners VII LLC For: Sep 30
-
Form 13F-HR Canaan Partners VII LLC For: Jun 30
-
Form 13F-HR Canaan Partners VII LLC For: Mar 31
-
Notable Mergers and Acquisitions 1/14: (MHK) (ZAYO) (RGDO)
-
Regado Biosciences (RGDO), Tobira Therapeutics Enter Merger Agreement
-
Form 4 LendingClub Corp For: Dec 16 Filed by: Canaan Partners VII LLC
-
Form 4 Dermira, Inc. For: Oct 08 Filed by: Canaan Partners VIII LLC
-
Form 4 MARINUS PHARMACEUTICALS For: Sep 30 Filed by: Canaan Partners VII LLC
-
Upcoming LendingClub IPO Scores High at Triton Research
-
Form 4 MARINUS PHARMACEUTICALS For: Aug 05 Filed by: Canaan Partners VII LLC
-
Rocketrip Lands $2.6 Million Series A Round
-
Genome Medical CEO to Speak at BIO 2017


